Huapont Life Sciences Co Ltd (002004) — Financial Flexibility Index
Huapont Life Sciences Co Ltd (002004) has a Financial Flexibility Index of 0.06x as of September 2025. Free cash flow of CN¥795.22 Million (operating CF CN¥635.17 Million minus capex CN¥160.05 Million) represents 0% of total liabilities (CN¥13.15 Billion). Check 002004 strategic asset allocation to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Huapont Life Sciences Co Ltd Financial Flexibility Index (2002–2025)
Historical Financial Flexibility Index trend for Huapont Life Sciences Co Ltd across 24 annual periods. See Huapont Life Sciences Co Ltd current assets vs equity to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Huapont Life Sciences Co Ltd (2002–2025)
Year-by-year free cash flow to debt coverage for Huapont Life Sciences Co Ltd. For the full company profile including market capitalisation, see market cap of Huapont Life Sciences Co Ltd.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.23x | CN¥2.73 Billion | CN¥2.10 Billion | CN¥12.05 Billion | ▲ +22.9% |
| 2024 | 0.18x | CN¥2.58 Billion | CN¥1.63 Billion | CN¥13.98 Billion | ▼ -9.1% |
| 2023 | 0.20x | CN¥2.87 Billion | CN¥1.59 Billion | CN¥14.14 Billion | ▼ -22.6% |
| 2022 | 0.26x | CN¥3.54 Billion | CN¥2.41 Billion | CN¥13.47 Billion | ▲ +47.9% |
| 2021 | 0.18x | CN¥2.53 Billion | CN¥1.27 Billion | CN¥14.22 Billion | ▼ -30.6% |
| 2020 | 0.26x | CN¥3.60 Billion | CN¥2.37 Billion | CN¥14.09 Billion | ▼ -2.6% |
| 2019 | 0.26x | CN¥3.52 Billion | CN¥2.08 Billion | CN¥13.39 Billion | ▲ +20.4% |
| 2018 | 0.22x | CN¥3.01 Billion | CN¥1.91 Billion | CN¥13.80 Billion | ▲ +120.1% |
| 2017 | 0.10x | CN¥1.56 Billion | CN¥591.40 Million | CN¥15.79 Billion | ▲ +15.1% |
| 2016 | 0.09x | CN¥1.16 Billion | CN¥511.90 Million | CN¥13.52 Billion | ▼ -31.9% |
| 2015 | 0.13x | CN¥1.17 Billion | CN¥342.45 Million | CN¥9.30 Billion | ▼ -5.0% |
| 2014 | 0.13x | CN¥1.04 Billion | CN¥455.96 Million | CN¥7.84 Billion | ▼ -33.8% |
| 2013 | 0.20x | CN¥729.31 Million | CN¥349.51 Million | CN¥3.64 Billion | ▲ +3.8% |
| 2012 | 0.19x | CN¥572.96 Million | CN¥257.75 Million | CN¥2.97 Billion | ▲ +34.1% |
| 2011 | 0.14x | CN¥230.99 Million | CN¥135.23 Million | CN¥1.60 Billion | ▼ -66.0% |
| 2010 | 0.42x | CN¥136.71 Million | CN¥79.84 Million | CN¥322.58 Million | ▼ -47.1% |
| 2009 | 0.80x | CN¥196.99 Million | CN¥123.53 Million | CN¥245.68 Million | ▲ +26.4% |
| 2008 | 0.63x | CN¥206.25 Million | CN¥113.76 Million | CN¥325.26 Million | ▲ +11.6% |
| 2007 | 0.57x | CN¥203.23 Million | CN¥79.21 Million | CN¥357.78 Million | ▲ +20.8% |
| 2006 | 0.47x | CN¥113.87 Million | CN¥66.10 Million | CN¥242.18 Million | ▼ -80.2% |
| 2005 | 2.37x | CN¥88.12 Million | CN¥43.69 Million | CN¥37.17 Million | ▲ +93.2% |
| 2004 | 1.23x | CN¥97.43 Million | CN¥70.60 Million | CN¥79.39 Million | ▲ +12.2% |
| 2003 | 1.09x | CN¥87.50 Million | CN¥56.68 Million | CN¥79.99 Million | ▲ +28.1% |
| 2002 | 0.85x | CN¥89.59 Million | CN¥36.88 Million | CN¥104.91 Million | — |